Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene completes acquisition of Avila Therapeutics
Yahoo/Fly on the Wall
Thursday, March 8, 2012 - 10:11am
tags:
Celgene, M&A, Avila
Zalicus May Be 2012's 'Come Back Kid' Biotech Stock
Seeking Alpha
Thursday, March 8, 2012 - 10:00am
tags:
Zalicus, Z160, Keryx, Aeterna Zentaris
NeurogesX Fails to Win U.S. Approval to Sell Patch for HIV-Related Pain
Bloomberg
Thursday, March 8, 2012 - 9:59am
tags:
FDA, HIV, NeurogesX, HIV-related pain, Qutenza
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows
Bloomberg
Thursday, March 8, 2012 - 9:57am
tags:
melanoma, Bristol-Myers Squibb, radiation therapy, Yervoy
AZN's FluMist Quadrivalent Approved
Yahoo/Zacks
Thursday, March 8, 2012 - 9:56am
tags:
AstraZeneca, FluMist Quadrivalent, Flu
Study finds Aricept still helps when Alzheimer's patients progress to moderate-to-severe stage
Yahoo/AP
Thursday, March 8, 2012 - 9:56am
tags:
Aricept, Alzheimer's disease, Pfizer, Lundbeck, Namenda
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thursday, March 8, 2012 - 9:55am
tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877
Gilead’s Experimental 4-in-1 AIDS Pill Effective as Current Drug in Study
Bloomberg
Wednesday, March 7, 2012 - 3:36pm
tags:
AIDS, HIV, Gilead, Atripla, Quad
Simcere Pharmaceutical jumps on strong 4Q results
Yahoo/AP
Wednesday, March 7, 2012 - 3:34pm
tags:
earnings, Simcere, China
Allergan Wins U.S. Court Order Blocking Sales of Merz’s Botox Competitor
Bloomberg
Wednesday, March 7, 2012 - 3:33pm
tags:
Allergan, Merz, Botox, Xeomin
Forest, Pierre Fabres: depression-drug progress
Marketwatch
Wednesday, March 7, 2012 - 3:32pm
tags:
Pierre Fabres, Forest Labs, depression, levomilnacipran
Bayer Considers Bid for Pfizer Animal-Health Unit
Bloomberg
Wednesday, March 7, 2012 - 3:29pm
tags:
Pfizer, Bayer, animal health, M&A
Consumer group sues 8 drugmakers over drug coupons
Yahoo/AP
Wednesday, March 7, 2012 - 3:25pm
tags:
drug coupons, lawsuits, Pfizer, Abbott Laboratories, Amgen, AstraZeneca, GSK, Bristol-Myers Squibb, Novartis, Merck
Viagra Would Need Therapist OK in Ohio Bill
Bloomberg
Wednesday, March 7, 2012 - 3:21pm
tags:
erectile dysfunction, Ohio, Viagra
GlaxoSmithKline resumes search for consumer drugs buyer, Reuters says
Yahoo/Fly on the Wall
Wednesday, March 7, 2012 - 10:37am
tags:
GSK, OTC, M&A
Drugmaker Eli Lilly starts sales this week for combination diabetes treatment Jentadueto
Yahoo/AP
Wednesday, March 7, 2012 - 10:15am
tags:
Eli Lilly, diabetes, Jentadueto, metformin, Tradjenta
Dynavax posts smaller 4Q loss as payments increase
Yahoo/AP
Wednesday, March 7, 2012 - 10:13am
tags:
Dynavax, earnings
Discovery Labs Wins Approval for Drug to Ease Baby Breathing
Bloomberg
Wednesday, March 7, 2012 - 10:13am
tags:
FDA, Discovery Labs, Surfaxin
Sanofi CEO interested in emerging-market deals
Reuters
Wednesday, March 7, 2012 - 10:12am
tags:
Sanofi, Pharma CEOs, emerging markets, Chris Viehbacher
Anxiously Awaiting Abbott's Plans To Split Into Two
Seeking Alpha
Wednesday, March 7, 2012 - 10:09am
tags:
Abbott Laboratories, Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.